JULY - 20225CXO INSIGHTSPERSPECTIVES ON THE CURRENT LANDSCAPE OF TRANSCATHETER THERAPIES FOR AORTIC AND MITRAL VALVE DISEASEGilbert H. L. Tang,Surgical Director, Structural Heart Program,Mount Sinai Hospital19LEVERAGING TECHNOLOGY TO BOOST MEDICAL DEVICE MANUFACTURINGJorge Lopes,President,Olympus Surgical Technologies of America26AI AND ML IN SOFTWARE AS A MEDICAL DEVICEToufic Kachaamy,Medical Director,Cancer Treatment Centers of America23BLOOD FLOW RESTRICTION THERAPY (BFR): ENTERING UNCHARTED TERRITORYCorbin Hedt, PT, DPT, SCS, CSCS,Clinical Research Director, Houston Methodist22THE WINDS OF CHANGE IN HEALTH CARE TODAYDavid Lubarsky,CEO,UC Davis Medical Center28COMPREHENSIVE, USER-CENTRIC DESIGN: THE FUTURE OF MEDICAL DEVICE INNOVATION Marco Dolci,President, Cardiopulmonary,LivaNova [NASDAQ:LIVN]24TOP 10SOLUTIONS PROVIDERS - 2022SURGICALFEATURED COMPANYLAZURITE 18Dr. Paula Doyle,Chief Medical Officer21EndoGlow
< Page 4 | Page 6 >